Incorporating Venetoclax Into Treatment Regimens For AML

Incorporating Venetoclax Into Treatment Regimens For AML

obr

1 year
21 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Samer Khaled, MD, Assistant Clinical Professor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, discusses Incorporating Venetoclax Into Treatment Regimens For AML. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com
Up Next Autoplay